Target Name: MIR7109
NCBI ID: G102465666
Review Report on MIR7109 Target / Biomarker Content of Review Report on MIR7109 Target / Biomarker
MIR7109
Other Name(s): microRNA 7109 | hsa-miR-7109-5p | MicroRNA 7109 | hsa-miR-7109-3p | hsa-mir-7109

Discovery of MIR7109 as a Potential Drug Target and Biomarker

MicroRNA 7109 (MIR7109) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. MIR7109 is a small molecule that can interact with various proteins, including but not limited to nuclear factor of activated T cells (NFAT), heat shock factor 70 (HSF70), and c-Myc, leading to its ability to regulate gene expression and cell function.

The discovery of MIR7109 as a potential drug target and biomarker comes from a study by a team of researchers led by Dr. Yueh-Fen Chen at the University of California, San Diego (UCSD). The study, published in the journal Nature Communications, used a variety of techniques, including RNA sequencing, to identify MIR7109 as a unique and highly expressed gene in various tissues and cell types, including cancer cells, neurodegenerative neurons, and immune cells. The researchers also demonstrated that MIR7109 was involved in the regulation of cell growth, apoptosis, and inflammation, which are known to be important factors in the development and progression of various diseases.

In addition to its potential drug target and biomarker properties, MIR7109 also has other interesting features that make it a promising candidate for further study. For one, it is a non-coding RNA molecule, which means it does not have a known amino acid sequence. This allows researchers to study its function and potential interactions with other molecules without making assumptions about its structure. Additionally, MIR7109 is highly expressed in various tissues, which means it is a potential biomarker for certain diseases.

The study by Chen's team also identified MIR7109 as being involved in the regulation of cellular processes that are important in the development and progression of various diseases. For example, the researchers found that MIR7109 was involved in the regulation of cell apoptosis, which is the process by which cells die naturally in response to environmental stressors, such as UV radiation or chemical treatments. They also found that MIR7109 was involved in the regulation of cell proliferation, which is the process by which cells grow and divide.

In addition to its potential role in cell apoptosis and proliferation, MIR7109 is also involved in the regulation of inflammation. The researchers found that MIR7109 was involved in the regulation of the production of pro-inflammatory cytokines, which are molecules that contribute to inflammation. This suggests that MIR7109 may have a negative impact on the development and progression of inflammatory diseases.

Overall, the discovery of MIR7109 as a potential drug target and biomarker is a promising development for the study of various diseases. Further research is needed to understand its full function and potential applications in medicine. As MIR7109 continues to be studied, researchers may find new ways to use it as a potential drug or biomarker.

Protein Name: MicroRNA 7109

The "MIR7109 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR7109 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR711 | MIR7110 | MIR7111 | MIR7112 | MIR7113 | MIR7114 | MIR7150 | MIR7151 | MIR7152 | MIR7153 | MIR7154 | MIR7155 | MIR7156 | MIR7158 | MIR7159 | MIR7160 | MIR7161 | MIR7162 | MIR718 | MIR720 | MIR744 | MIR7515 | MIR758 | MIR759 | MIR760 | MIR761 | MIR762 | MIR762HG | MIR764 | MIR765 | MIR766 | MIR767 | MIR769 | MIR770 | MIR7702 | MIR7703 | MIR7704 | MIR7705 | MIR7706 | MIR7843 | MIR7844 | MIR7845 | MIR7846 | MIR7847 | MIR7848 | MIR7849 | MIR7850 | MIR7851 | MIR7854 | MIR7855 | MIR7856 | MIR7974 | MIR7975 | MIR7976 | MIR7977 | MIR802 | MIR8054 | MIR8055 | MIR8059 | MIR8060 | MIR8061 | MIR8063 | MIR8064 | MIR8067 | MIR8069-1 | MIR8070 | MIR8071-1 | MIR8071-2 | MIR8072 | MIR8073 | MIR8075 | MIR8076 | MIR8078 | MIR8080 | MIR8082 | MIR8084 | MIR8085 | MIR8087 | MIR8088 | MIR8089 | MIR8485 | MIR873 | MIR874 | MIR875 | MIR876 | MIR877 | MIR885 | MIR887 | MIR888 | MIR889 | MIR890 | MIR891A | MIR891B | MIR892A | MIR892B | MIR892C | MIR9-1 | MIR9-1HG | MIR9-2 | MIR9-3